AbCellera Biologics (ABCL) Debt Ratio: 2020-2025
Historic Debt Ratio for AbCellera Biologics (ABCL) over the last 4 years, with Mar 2025 value amounting to 0.01.
- AbCellera Biologics' Debt Ratio fell 81.44% to 0.01 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.01, marking a year-over-year decrease of 81.44%. This contributed to the annual value of 0.01 for FY2024, which is 82.48% down from last year.
- Per AbCellera Biologics' latest filing, its Debt Ratio stood at 0.01 for Q1 2025, which was up 9.78% from 0.01 recorded in Q4 2024.
- Over the past 5 years, AbCellera Biologics' Debt Ratio peaked at 0.04 during Q2 2023, and registered a low of 0.01 during Q4 2024.
- In the last 3 years, AbCellera Biologics' Debt Ratio had a median value of 0.03 in 2023 and averaged 0.02.
- In the last 5 years, AbCellera Biologics' Debt Ratio skyrocketed by 113.92% in 2022 and then plummeted by 82.48% in 2024.
- AbCellera Biologics' Debt Ratio (Quarterly) stood at 0.02 in 2021, then spiked by 64.96% to 0.03 in 2022, then increased by 18.22% to 0.03 in 2023, then slumped by 82.48% to 0.01 in 2024, then crashed by 81.44% to 0.01 in 2025.
- Its Debt Ratio stands at 0.01 for Q1 2025, versus 0.01 for Q4 2024 and 0.01 for Q3 2024.